Hyper Scalable Biotech
Next-generation pharma powered by automated trials to advance programs at scale
AI Designed Therapeutics
TARGET DISCOVERY
MOLECULE DESIGN
Rapid Experimental Validation
Vial is advancing best-in-class RNA, antibody, and small molecule programs with the following approach:
TARGET DISCOVERY
1
Target Discovery
Vial evaluates target biology and pre-clinical and clinical datasets to identify high-value therapeutic targets.
MOLECULE DESIGN
2
Molecule Design
Molecular designs are generated, evaluated, and optimized through iterative design loops to ultimately advance a development candidates.
Rapid Experimental Validation
3
Experimental Validation
Vial is enabled by high-throughput approaches to validate programs and accelerate development.
Automated Clinical Trials
Programs are evaluated in clinical trials powered by Vial’s clinical trial platform.
Focus Areas
Obesity
Immunology
Contact
Get in touch
"*" indicates required fields
